These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37706492)

  • 1. Sarcopenia and treatment failure in inflammatory bowel disease: a systematic review and meta-analysis.
    Feng Y; Feng W; Xu M; Wu C; Yang H; Wang Y; Gan H
    Rev Esp Enferm Dig; 2024 Feb; 116(2):68-76. PubMed ID: 37706492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between autism spectrum disorder and inflammatory bowel disease: A systematic review and meta-analysis.
    Kim JY; Choi MJ; Ha S; Hwang J; Koyanagi A; Dragioti E; Radua J; Smith L; Jacob L; Salazar de Pablo G; Lee SW; Yon DK; Thompson T; Cortese S; Lollo G; Liang CS; Chu CS; Fusar-Poli P; Cheon KA; Shin JI; Solmi M
    Autism Res; 2022 Feb; 15(2):340-352. PubMed ID: 34939353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid Use Among Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Niccum B; Moninuola O; Miller K; Khalili H
    Clin Gastroenterol Hepatol; 2021 May; 19(5):895-907.e4. PubMed ID: 32835841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.
    Sinopoulou V; Gordon M; Akobeng AK; Gasparetto M; Sammaan M; Vasiliou J; Dovey TM
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013531. PubMed ID: 34844288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Bidirectional Association between Inflammatory Bowel Disease and Atopic Dermatitis: A Systematic Review and Meta-Analysis.
    Shi X; Chen Q; Wang F
    Dermatology; 2020; 236(6):546-553. PubMed ID: 31955167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of venous thromboembolism in children and adolescents with inflammatory bowel disease: A systematic review and meta-analysis.
    Zhang XY; Dong HC; Wang WF; Zhang Y
    World J Gastroenterol; 2022 Apr; 28(16):1705-1717. PubMed ID: 35581968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of uterine cervical cancer in inflammatory bowel disease: a systematic review and meta-analysis.
    Kim J; Jung JH; Jo H; Kim MH; Kang DR; Kim HM
    Scand J Gastroenterol; 2023; 58(12):1412-1421. PubMed ID: 37517000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global Prevalence and Bidirectional Association Between Psoriasis and Inflammatory Bowel Disease-A Systematic Review and Meta-analysis.
    Alinaghi F; Tekin HG; Burisch J; Wu JJ; Thyssen JP; Egeberg A
    J Crohns Colitis; 2020 Mar; 14(3):351-360. PubMed ID: 31504363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review of sarcopenia in inflammatory bowel disease.
    Fatani H; Olaru A; Stevenson R; Alharazi W; Jafer A; Atherton P; Brook M; Moran G
    Clin Nutr; 2023 Aug; 42(8):1276-1291. PubMed ID: 37352818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between inflammatory bowel diseases and Parkinson's disease: systematic review and meta-analysis.
    Zhu Y; Yuan M; Liu Y; Yang F; Chen WZ; Xu ZZ; Xiang ZB; Xu RS
    Neural Regen Res; 2022 Feb; 17(2):344-353. PubMed ID: 34269209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcopenia is associated with poor clinical outcomes in patients with inflammatory bowel disease: a prospective cohort study.
    Liu S; Ding X; Maggiore G; Pietrobattista A; Satapathy SK; Tian Z; Jing X
    Ann Transl Med; 2022 Mar; 10(6):367. PubMed ID: 35433981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review: Sarcopenia in paediatric inflammatory bowel disease.
    Aljilani B; Tsintzas K; Jacques M; Radford S; Moran GW
    Clin Nutr ESPEN; 2023 Oct; 57():647-654. PubMed ID: 37739718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Relationship Between Opioid Use and Healthcare Utilization in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Sheehan JL; Jacob J; Berinstein EM; Greene-Higgs L; Steiner CA; Berry SK; Shannon C; Cohen-Mekelburg SA; Higgins PDR; Berinstein JA
    Inflamm Bowel Dis; 2022 Dec; 28(12):1904-1914. PubMed ID: 35230420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of metabolic syndrome in patients with inflammatory bowel disease: a systematic review and meta-analysis.
    Shen Z; Zhang M; Liu Y; Ge C; Lu Y; Shen H; Zhu L
    BMJ Open; 2024 Mar; 14(3):e074659. PubMed ID: 38453206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: Putting some muscle into sarcopenia-the pathogenesis, assessment and clinical impact of muscle loss in patients with inflammatory bowel disease.
    Gold SL; Raman M; Sands BE; Ungaro R; Sabino J
    Aliment Pharmacol Ther; 2023 Jun; 57(11):1216-1230. PubMed ID: 37051722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
    Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Inflammatory Bowel Diseases and Celiac Disease: A Systematic Review and Meta-Analysis.
    Pinto-Sanchez MI; Seiler CL; Santesso N; Alaedini A; Semrad C; Lee AR; Bercik P; Lebwohl B; Leffler DA; Kelly CP; Moayyedi P; Green PH; Verdu EF
    Gastroenterology; 2020 Sep; 159(3):884-903.e31. PubMed ID: 32416141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory bowel disease and risk of urinary cancers: a systematic review and pooled analysis of population-based studies.
    Feng D; Yang Y; Wang Z; Wei W; Li L
    Transl Androl Urol; 2021 Mar; 10(3):1332-1341. PubMed ID: 33850767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease.
    Miao XP; Li JS; Ouyang Q; Hu RW; Zhang Y; Li HY
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD007744. PubMed ID: 25340915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.